# Effectiveness of multidisciplinary rehabilitation on functional recovery in post-COVID-19 patients: a multicentric study across Ecuadorian healthcare centers

**Authors:** Paola Yepez, Juan D. Martinez-Lemus, Alejandra Mafla-Viscarra, Fernando Ortega Pérez, David Sebastián Peña Campos, Jorge Elías Rodríguez Arias, Evelyn Caballero Caballero, Mirely Tobar, Killen H. Briones-Zamora, Killen H. Briones-Claudett, Michelle Grunauer

PMC · DOI: 10.3389/fmed.2026.1711031 · Frontiers in Medicine · 2026-02-13

## TL;DR

A study in Ecuador found that multidisciplinary rehabilitation improves recovery for post-COVID-19 patients, but those with long-term symptoms recover less functionally.

## Contribution

The study provides evidence on the effectiveness of multidisciplinary rehabilitation for post-COVID-19 patients in a low- to middle-income country context.

## Key findings

- Multidisciplinary rehabilitation improved functional status and perceived health over 12 weeks.
- Patients with post-COVID-19 condition (PCC) showed less functional recovery compared to non-PCC patients.
- Baseline PCC status was strongly associated with lower odds of functional improvement.

## Abstract

Post-COVID-19 condition (PCC) poses a major challenge for health systems, particularly in low- and middle-income countries, where evidence on the benefits of multidisciplinary rehabilitation remains limited.

To evaluate changes in functional and perceived health over 12 weeks of multidisciplinary rehabilitation and to determine whether recovery differed between patients with and without PCC.

We conducted a multicentric, longitudinal cohort study of adults with confirmed COVID-19 enrolled in a multidisciplinary rehabilitation program. PCFS and AVS were evaluated at baseline and at 4-week intervals through Week 12. Patients were classified by PCC status at enrollment. Group comparisons, longitudinal analyses, and logistic regression models (unadjusted and adjusted) were performed to assess changes over time and factors associated with reduced functional improvement. Analyses were conducted using SPSS V.25 and GraphPad Prism V.10.

A total of 477 patients were enrolled; 354 (74.2%) met PCC criteria at baseline (enrollment), and 123 (25.8%) were classified as non-PCC. Follow-up completion for PCFS was 351 patients at Week 4 (73.6%), 330 at Week 8 (69.2%), and 250 at Week 12 (52.4%). At baseline, PCC patients were younger (p = 0.030), had more comorbidities (p < 0.001), and differed in education (p = 0.007), occupation (p = 0.012), and initial provider type (p = 0.004), while sex did not differ (p = 0.299). Over 12 weeks, PCFS decreased by 0.48 points (95% CI –0.65 to −0.31, p < 0.0001) and AVS increased by 0.68 points (95% CI 0.56–0.80, p < 0.0001). In adjusted models, baseline PCC was strongly associated with lower odds of PCFS improvement (aOR 0.27, 95% CI 0.13–0.56, p < 0.001). AVS improvement did not differ by baseline PCC status (p = 0.062).

Multidisciplinary rehabilitation improved both functional status and perceived health; however, patients with baseline PCC showed less functional recovery. These findings underscore the importance of early identification of PCC status at enrollment and emphasize the need for targeted rehabilitation.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** cognitive impairment (MESH:D003072), PCFS (MESH:D000094024), chronic pulmonary diseases (MESH:D002908), infectious diseases (MESH:D003141), interstitial lung diseases (MESH:D017563), myalgia (MESH:D063806), depression (MESH:D003866), chronic pain (MESH:D059350), cough (MESH:D003371), deep vein thrombosis (MESH:D020246), infection (MESH:D007239), COVID (MESH:D000086382), Symptom (MESH:D012816), cardiac ischemia (MESH:D007511), pulmonary embolism (MESH:D011655), inability (MESH:C564980), fatigue (MESH:D005221), chronic obstructive pulmonary disease (MESH:D029424), respiratory conditions (MESH:D012131), arrhythmias (MESH:D001145), anxiety (MESH:D001007), psychiatric disorders (MESH:D001523), dyspnea (MESH:D004417), respiratory illness (MESH:D012140)
- **Chemicals:** PCC (-), oxygen (MESH:D010100)
- **Species:** Enterovirus C (no rank) [taxon 138950], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12959126/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12959126/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12959126/full.md

---
Source: https://tomesphere.com/paper/PMC12959126